Scavenger Receptors as Biomarkers and Therapeutic Targets in Cardiovascular Disease

• Published in: Cells (Basel, Switzerland) Vol. 9; no. 11; p. 2453
• Main Authors: Cuthbert, Gary A, Shaik, Faheem, Harrison, Michael A, Ponnambalam, Sreenivasan, Homer-Vanniasinkam, Shervanthi
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 10.11.2020; MDPI
• Subjects: atherosclerosis; Atherosclerosis - therapy; Biological markers; Biomarkers - metabolism; cardiovascular disease; Cardiovascular diseases; Cardiovascular Diseases - therapy; Care and treatment; Cell receptors; Diagnosis; Health aspects; Humans; lipids; Physiological aspects; Receptors, Scavenger - metabolism; Review; scavenger receptors; United Kingdom; atherosclerosis; cardiovascular disease; lipids; scavenger receptors
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells9112453

The process of atherosclerosis leads to the formation of plaques in the arterial wall, resulting in a decreased blood supply to tissues and organs and its sequelae: morbidity and mortality. A class of membrane-bound proteins termed scavenger receptors (SRs) are closely linked to the initiation and progression of atherosclerosis. Increasing interest in understanding SR structure and function has led to the idea that these proteins could provide new routes for cardiovascular disease diagnosis, management, and treatment. In this review, we consider the main classes of SRs that are implicated in arterial disease. We consider how our understanding of SR-mediated recognition of diverse ligands, including modified lipid particles, lipids, and carbohydrates, has enabled us to better target SR-linked functionality in disease. We also link clinical studies on vascular disease to our current understanding of SR biology and highlight potential areas that are relevant to cardiovascular disease management and therapy.